Department of Liver Surgery Second Affiliated Hospital of Harbin Medical University 150081;
Department of General Surgery Fourth Affiliated Hospital of Harbin Medical University 150001;
Department of Cardiothoracic Surgery Second Affiliated Hospital of Harbin Medical University 150081;
Department of Gastrointestinal Surgery First Affiliated Hospital of Gannan Medical University 341099;
Department of Physical Examination Center Second Affiliated Hospital of Harbin Medical University 150081;
CRYPTOTANSHINONE; SORAFENIB; sorafenib-resistance; STAT3 signaling; liver cancer;